Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00973804
What this trial is testing

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Who this might be right for
LeukemiaNon-Hodgkins LymphomaHodgkins Lymphoma+2 more
National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)Study completedNCT00002678
What this trial is testing

Combination Chemotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 595
Testing effectiveness (Phase 2)Study completedNCT00911859
What this trial is testing

Compare CNTO 328 (Anti-IL-6 Monoclonal Antibody) and VELCADE-Melphalan-Prednisone (VMP) With VMP Alone in Previously Untreated Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 118
Post-approval studies (Phase 4)Ended earlyNCT05161468
What this trial is testing

Platelet-rich Plasma, Corticosteroid, or Lidocaine for Acromioclavicular Joint Pain

Who this might be right for
Acromioclavicular Sprain
Brooke Army Medical Center 34
Not applicableUnknownNCT05914350
What this trial is testing

Comparison Between Ultrasound Guided Ozone, Platelet-Rich Plasma or Steroid Injection in the Treatment of Sacroiliitis; a Randomized Double Blinded Controlled Study

Who this might be right for
the Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of Sacroiliitis
Tanta University 105
Not applicableNo Longer AvailableNCT00063791
What this trial is testing

Assess Two Different Strategies of Combining Dexamethasone and VELCADE

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc.
Not applicableStudy completedNCT05782920
What this trial is testing

Management of Cancer Therapy Related Vulvovaginal Atrophy

Who this might be right for
Genitourinary Syndrome of Menopause
Alexandria University 45
Testing effectiveness (Phase 2)Study completedNCT00724568
What this trial is testing

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 74
Very early researchNot Yet RecruitingNCT06664268
What this trial is testing

Effect of PRF & Fractional CO2 Laser in Postburn Hypertrophic Scars

Who this might be right for
Hypertrophic ScarsBurn Scar Patients
Assiut University 30
Not applicableEnded earlyNCT01662349
What this trial is testing

Safety Study of Plasma Treatment System to Treat Back Acne

Who this might be right for
Acne Vulgaris
Moe Medical Devices 8
Early research (Phase 1)Looking for participantsNCT07075185
What this trial is testing

Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Kelonia Therapeutics, Inc. 70
Post-approval studies (Phase 4)UnknownNCT02999217
What this trial is testing

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Who this might be right for
Anemia, Iron-DeficiencyIntravenous Drug UsageColorectal Neoplasms+1 more
Kaunas University of Medicine 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04635189
What this trial is testing

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Rochester 28
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Not applicableStudy completedNCT03963089
What this trial is testing

Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children

Who this might be right for
Plasma VolumeTidal Volume
Seoul National University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT01239368
What this trial is testing

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-MultipleMyelomatosis
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00586014
What this trial is testing

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 91
Testing effectiveness (Phase 2)Study completedNCT03860038
What this trial is testing

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseRefractory Multiple Myeloma
TJ Biopharma Co., Ltd. 113
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Not applicableNot Yet RecruitingNCT07034755
What this trial is testing

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University 20
Next Page